INTECH Investment Management’s Pacific Biosciences PACB Stock Holding History

INTECH Investment Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113K	Sell	67,410 -33,961	-34%	-$49.4K	﹤0.01%	1925
2026 Q1	$134K	Sell	101,371 -22,565	-18%	-$40.4K	﹤0.01%	1842
2025 Q4	$232K	Sell	123,936 -8,432	-6%	-$16.2K	﹤0.01%	1898
2025 Q3	$169K	Buy	132,368 +6,564	+5%	+$8.89K	﹤0.01%	2123
2025 Q2	$156K	Sell	125,804 -61,382	-33%	-$70.9K	﹤0.01%	2178
2025 Q1	$221K	Buy	187,186 +52,044	+39%	+$79.8K	﹤0.01%	2039
2024 Q4	$247K	Buy	135,142 +23,305	+21%	+$45.5K	﹤0.01%	1928
2024 Q3	$190K	Buy	+111,837	New	+$184K	﹤0.01%	1746

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

INTECH Investment Management's PACB Position: Q2 2026 in Review

INTECH Investment Management reduced its Pacific Biosciences (PACB) stake by 34% in Q2 2026, selling an estimated $49.4K and leaving 67,410 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

INTECH Investment Management first reported a position in PACB in Q3 2024 and has held it in 8 quarters since. The position peaked at $247K in Q4 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

INTECH Investment Management held 67,410 shares of Pacific Biosciences worth $113K as of Q2 2026.
INTECH Investment Management sold 33,961 Pacific Biosciences shares in Q2 2026, an estimated $49.4K.
Pacific Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1925 holding.
INTECH Investment Management first reported a position in Pacific Biosciences in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Pacific Biosciences position peaked at $247K in Q4 2024.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.